FDC

FDC

Small Cap BSE: 531599 NSE: FDC
₹238.65
2.9 (1.23%)
As on 30 June, 2022 | 19:15

Fdc Share Price

Fdc Share Returns

  • Over 1 Month -2.61%
  • Over 3 Month -7.39%
  • Over 6 Month -21.81%
  • Over 1 Year -32.58%

Fdc Key Statistics

Fdc Investment Rating

  • Master Rating:
  • F D C (Nse) has an operating revenue of Rs. 1,527.92 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 19% is great, ROE of 11% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 46 which is a POOR score indicating inconsistency in earnings, a RS Rating of 16 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 106 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

FDC Financials
  • Indicator
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev
    Qtr Cr
  • 336.61
  • 341.11
  • 396.28
  • 444.96
  • 311.55
  • Operating Expenses
    Qtr Cr
  • 319.40
  • 297.66
  • 324.14
  • 330.92
  • 274.20
  • Operating Profit
    Qtr Cr
  • 17.21
  • 43.45
  • 72.14
  • 114.04
  • 37.35
  • Depreciation
    Qtr Cr
  • 9.16
  • 8.99
  • 9.44
  • 9.50
  • 9.48
  • Interest
    Qtr Cr
  • 0.69
  • 0.84
  • 0.72
  • 0.80
  • 1.05
  • Tax
    Qtr Cr
  • 4.58
  • 15.15
  • 19.01
  • 27.07
  • 6.95
  • Net Profit
    Qtr Cr
  • 14.38
  • 31.59
  • 73.55
  • 100.11
  • 41.96

Fdc Technicals

EMA & SMA

Current Price
238.65
2.9 (1.23%)
  • Bullish Moving Average
  • ___
  • 6
  • Bearish Moving Average
  • ___
  • 10
  • 20 Day
  • 238.99
  • 50 Day
  • 247.86
  • 100 Day
  • 261.91
  • 200 Day
  • 288.42
  • 20 Day
  • 238.09
  • 50 Day
  • 249.37
  • 100 Day
  • 263.25
  • 200 Day
  • 288.38

Fdc Resistance and Support

PIVOT
₹239.52
Resistance
  • First Resistance
  • 244.24
  • Second Resistance
  • 252.72
  • Third Resistance
  • 257.44
Support
  • First Resistance
  • 231.04
  • Second Resistance
  • 226.32
  • Third Resistance
  • 217.84
  • RSI
  • 47.4
  • MFI
  • 46.45
  • MACD Single Line
  • -4.34
  • MACD
  • -3.27

Fdc Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 40,721
  • 1,768,513
  • 43.43
  • Week
  • 109,326
  • 7,418,835
  • 67.86
  • 1 Month
  • 68,357
  • 4,576,474
  • 66.95
  • 6 Month
  • 189,783
  • 9,781,410
  • 51.54

Fdc Result Highlights

FDC Synopsis

NSE-Medical-Diversified

Fdc is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 1325.45 Cr. and Equity Capital is Rs. 16.88 Cr. for the Year ended 31/03/2021. FDC Ltd. is a Public Limited Listed company incorporated on 23/09/1940 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1940PLC003176 and registration number is 003176.
  • Market Cap
  • 4,017.68
  • Sales
  • 1,518.97
  • Shares in Float
  • 5.23
  • No of funds
  • 91
  • Yield
  • 1.09
  • Book Value
  • 2.04
  • U/D Vol ratio
  • 0.5
  • LTDebt / Equity
  • Alpha
  • -0.14
  • Beta
  • 0.58

FDC

  • Owner Name
  • Jun -21
  • Promoters
  • 69.35%
  • Mutual Funds
  • 4.11%
  • Insurance Companies
  • 0.17%
  • Foreign Portfolio Investors
  • 4.76%
  • Financial Institutions/ Banks
  • %
  • Individual Investors
  • 16.82%
  • Others
  • 4.79%

FDC Management

  • Name
  • Designation
  • Mr. Ramdas A Chandavarkar
  • Chairman Emeritus
  • CA. Uday Kumar Gurkar
  • Chairman
  • Mr. Mohan A Chandavarkar
  • Managing Director
  • Mr. Nandan M Chandavarkar
  • Joint Managing Director
  • Mr. Ameya A Chandavarkar
  • Executive Director & CEO
  • Mr. Ashok A Chandavarkar
  • Executive Director
  • Ms. Nomita R Chandavarkar
  • Executive Director
  • CA. Swati S Mayekar
  • Ind. Non-Executive Director
  • Mr. Melarkode Ganesan Parameswaran
  • Ind. Non-Executive Director
  • Ms. Usha Athreya Chandrasekhar
  • Ind. Non-Executive Director
  • Dr. Mahesh Bijlani
  • Ind. Non-Executive Director

Fdc Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Fdc Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-05-25
  • Audited & Quarterly Results
  • 2022-02-09
  • Quarterly Results
  • 2021-11-11
  • Quarterly Results
  • 2021-08-12
  • Quarterly Results
  • 2021-05-26
  • Audited Results

FDC MF Shareholding

  • Name
  • Amount(cr)
  • Nippon India Small Cap Fund - Growth
  • 18675.43
  • ICICI Prudential Multi-Asset Fund Growth
  • 13279.38
  • ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
  • 2316.08
  • ICICI Prudential ESG Fund Regular Growth
  • 1396.29
  • IDFC Emerging Businesses Fund Regular Growth
  • 1337.65

Fdc News

FDC LTD. - 531599 - Closure of Trading Window

Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 & Amendments thereon and in compliance with Company''s Code of Conduct for the Prevention of Insider Trading and Code of Fair Disclosure, the Trading Window for dealing in Securities of the Company for all the Designated Persons, Connected Persons and their Immediate Relative(s), shall remain closed from Friday, July 01, 2022 until 48 hours after the declaration of the Unaudited Financial Results of the Company for the quarter ending June 30, 2022. The date of Board Meeting of the Company for consideration and approval of the Unaudited Financial Results for the quarter ending June 30, 2022 will be intimated in due course. Kindly take the same on record.

Glenmark Pharma launches first FDC drug Indamet for asthma patients

Glenmark Pharmaceuticals on Thursday said it has launched a novel fixed-dose combination (FDC) drug in the country for patients with uncontrolled asthma. The Mumbai-based drug major has launched - Indacaterol + Mometasone FDC under the brand name Indamet. The drug will be available in three strengths with a fixed dose of Indacaterol 150 mcg and variable doses of Mometasone 80 mcg, 160 mcg and 320 mcg to be taken once daily. "Respiratory is a key focus area for Glenmark, and the company leads from the front in providing access to the latest treatment options to patients. "We are proud to introduce this novel fixed-dose combination Indamet, which is the first of its kind in India, offering an affordable treatment option to both adults and adolescents 12 years of age and older suffering from uncontrolled asthma," Glenmark Pharmaceuticals Group Vice President & Head (India Formulations) Alok Malik said in a statement. The drug maker is the first company in India to market the FDC of .

FDC LTD. - 531599 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

Notice of Postal Ballot - Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations')

FDC LTD. - 531599 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Dear Sir/Madam, Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we have received information of loss / theft of share certificates and request for issue of duplicate share certificate. We have processed for issue of duplicate share certificate through Registrar & Share Transfer Agent (RTAs)

FDC LTD. - 531599 - Disclosure Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations. 2015

Dear Sir/Madam, Pursuant to Regulation 23(9) of the SEBI Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Disclosure of Related Party Transactions for the half year ended March 31, 2022. Kindly take the same on record.

FDC FAQs

What is Share Price of FDC ?

FDC share price is ₹238 As on 30 June, 2022 | 19:01

What is the Market Cap of FDC ?

The Market Cap of FDC is ₹4028.7 As on 30 June, 2022 | 19:01

What is the P/E ratio of FDC ?

The P/E ratio of FDC is 18.6 As on 30 June, 2022 | 19:01

What is the PB ratio of FDC ?

The PB ratio of FDC is 2.1 As on 30 June, 2022 | 19:01